In NSCLC patients undergoing anti-PD-L1 therapy, CSF1R and HCST expression levels showed a positive correlation with PD-L1 levels and a high presence of CD8+ T cells, indicating their potential predictive value for prognosis (98). Here, CD8A is linked to non-small cell lung carcinoma.